K2 Principal Fund, L.P. Vivos Therapeutics, Inc. Transaction History

K2 Principal Fund, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.71 - $5.9 $175,461 - $382,001	-64,746 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.83 - $9.67 $312,723 - $626,093	64,746 New	64,746 $320,000
Q1 2021 May 14, 2021	SELL	$6.01 - $8.9 $308,877 - $457,406	-51,394 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.91 - $9.11 $303,738 - $468,199	51,394 New	51,394 $304,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.